This inventor holds 2 USPTO granted patents. Top assignee: University of Central Florida Research Foundation Inc.. Active years: 2011-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2012
Title: The Innovative Contributions of Manny Vrotsos
Introduction
Manny Vrotsos is a notable inventor based in Orlando, FL. He has made significant contributions to the field of biocompatible materials, particularly in the development of tissue substitutes. With a total of 2 patents, his work focuses on enhancing the repair of damaged bones and tissues.
Latest Patents
Manny Vrotsos holds two recent patents that showcase his innovative approach. The first patent involves tissue substitutes comprising stem cells and reduced ceria. This biocompatible composite includes a solid biocompatible material and a plurality of living human progenitor or living stem cells attached to it. The composition results in accelerated repair to damaged bones and tissues. The second patent is similar in nature, also focusing on tissue substitutes comprising stem cells and reduced ceria. This biocomposite provides a stable interface with endogenous tissue, further enhancing the repair process for damaged bones and tissues.
Career Highlights
Manny Vrotsos is affiliated with the University of Central Florida Research Foundation, Inc. His work at this institution has allowed him to explore innovative solutions in the field of regenerative medicine. His research has the potential to significantly impact the way we approach tissue repair and regeneration.
Collaborations
Manny has collaborated with esteemed colleagues such as Kiminobu Sugaya and Stephanie Merchant. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Manny Vrotsos is a pioneering inventor whose work in biocompatible materials is paving the way for advancements in tissue repair. His contributions are vital to the future of regenerative medicine and highlight the importance of innovation in this field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
